FDA Issues Warning and Recall for Lipofit Extreme Fat Burner 2.0 Due to Undeclared Prescription Drug and Toxic Chemical
The U.S. Food and Drug Administration (FDA) has issued a warning and recall for Lipofit Extreme Fat Burner 2.0, a weight-loss supplement sold online. Testing conducted by the FDA revealed the presence of undeclared ingredients in the product. The AM tablets were found to contain fluoxetine, an active ingredient in FDA-approved prescription drugs used to treat conditions such as depression, bulimia, and obsessive-compulsive disorder. The PM tablets contained 2,4-dinitrophenol (DNP), a toxic substance used in pesticides, dyes, wood preservatives, and herbicides, which is not approved for any use and has been illegally marketed for weight loss. Ana Salazar Modela Tu Cuerpo Inc. initiated the recall for Lot 25M12F, which has an expiration date of September 2027. The product was distributed directly to consumers across the United States. As of the company's announcement, no adverse events related to the recalled product have been reported. 
